书信:转移因子转移因子

Same author

Immunodeficiency diseases.

Immunology series·1990

Same author

Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome.

Autoimmunity·1989

Same author

Transfer factor: past, present and future.

Annual review of pharmacology and toxicology·1989

Same author

Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease.

Immunology letters·1988

Same author

Implications of immunomodulant therapy in Alzheimer's disease.

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques·1988

Same author

Immunodiagnosis and immunotherapy in autistic children.

Annals of the New York Academy of Sciences·1988

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

书信:转移因子转移因子

相关概念视频

Immunodeficiency diseases.

Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome.

Transfer factor: past, present and future.

Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease.

Implications of immunomodulant therapy in Alzheimer's disease.

Immunodiagnosis and immunotherapy in autistic children.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

书信:转移因子转移因子

相关概念视频

相关文章

Immunodeficiency diseases.

Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome.

Transfer factor: past, present and future.

Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease.

Implications of immunomodulant therapy in Alzheimer's disease.

Immunodiagnosis and immunotherapy in autistic children.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.